STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 90 filers reported holding STOKE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $203,217 | -70.5% | 15,042 | -70.6% | 0.00% | -100.0% |
| Q1 2024 | $689,810 | +586.8% | 51,097 | +167.6% | 0.00% | – |
| Q4 2023 | $100,445 | +67.6% | 19,096 | +25.5% | 0.00% | – |
| Q3 2023 | $59,927 | -59.7% | 15,210 | -14.8% | 0.00% | -100.0% |
| Q1 2023 | $148,699 | -32.1% | 17,851 | +174.8% | 0.00% | 0.0% |
| Q2 2021 | $219,000 | -47.4% | 6,495 | -39.4% | 0.00% | -50.0% |
| Q1 2021 | $416,000 | +14.6% | 10,712 | -1.2% | 0.00% | -60.0% |
| Q3 2020 | $363,000 | -36.8% | 10,837 | -46.6% | 0.01% | +66.7% |
| Q4 2019 | $574,000 | +23.2% | 20,286 | -6.5% | 0.00% | -25.0% |
| Q3 2019 | $466,000 | – | 21,699 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $475,340,000 | 79.82% |
| RTW INVESTMENTS, LP | 3,544,248 | $100,373,000 | 3.79% |
| Cormorant Asset Management, LP | 1,788,643 | $50,654,000 | 2.02% |
| RA Capital Management | 1,119,963 | $31,717,000 | 0.96% |
| Redmile Group, LLC | 1,020,778 | $28,908,000 | 0.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 256,380 | $7,261,000 | 0.60% |
| GILDER GAGNON HOWE & CO LLC | 1,826,890 | $51,738,000 | 0.54% |
| Perceptive Advisors | 671,978 | $19,030,000 | 0.38% |
| Casdin Capital, LLC | 130,000 | $3,682,000 | 0.34% |
| Granite Point Capital Management, L.P. | 13,200 | $374,000 | 0.06% |